Management of Complications of BCMA-Directed Therapy in Relapsed Multiple Myeloma: A Focused Review

被引：0
|
作者：
Khanam, Razwana [1 ]
Batool, Saba [2 ]
Najmuddin, Mohammed Musa [3 ]
Usman, Rana [4 ]
Kuriakose, Kiran [5 ]
Ahmed, Arooj [6 ]
Rehman, Mohammad Ebad Ur [7 ]
Roksana, Zinath [8 ]
Anwer, Faiz [9 ]
机构：
[1] Baystate Med Ctr, Springfield, MA USA
[2] Unity Point Methodist Hosp, Peoria, IL USA
[3] Wright Ctr Grad Med Educ, Scranton, PA USA
[4] Univ Tennessee, Hlth Ctr, Memphis, TN USA
[5] UPMC Mercy, Pittsburgh, PA USA
[6] Cleveland Clin, Cleveland, OH 44106 USA
[7] Rawalpindi Med Univ, Rawalpindi, Pakistan
[8] Feni Sadar Hosp, Feni, Bangladesh
[9] Cleveland Clin, Dept Hematol & Med Oncol, Taussig Canc Inst, Cleveland, OH 44106 USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-164871
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：12494 / 12495
页数：2
相关论文
共 50 条
  • [1] Management of Adverse Reactions for BCMA-Directed Therapy in Relapsed Multiple Myeloma: A Focused Review
    Khanam, Razwana
    Faiman, Beth
    Batool, Saba
    Najmuddin, Mohammed Musa
    Usman, Rana
    Kuriakose, Kiran
    Ahmed, Arooj
    Rehman, Mohammad Ebad Ur
    Roksana, Zinath
    Syed, Zain
    Anwer, Faiz
    Raza, Shahzad
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (17)
  • [2] BCMA-directed therapy for early relapsed and/or refractory multiple myeloma
    van de Donk, Niels W. C. J.
    Zweegman, Sonja
    NATURE REVIEWS CLINICAL ONCOLOGY, 2024, 21 (10) : 707 - 708
  • [3] Comparison of infectious complications with BCMA-directed therapies in multiple myeloma
    Nath, Karthik
    Shekarkhand, Tala
    Nemirovsky, David
    Derkach, Andriy
    Costa, Bruno Almeida
    Nishimura, Noriko
    Farzana, Tasmin
    Rueda, Colin
    Chung, David J.
    Landau, Heather J.
    Lahoud, Oscar B.
    Scordo, Michael
    Shah, Gunjan L.
    Hassoun, Hani
    Maclachlan, Kylee
    Korde, Neha
    Shah, Urvi A.
    Tan, Carlyn Rose
    Hultcrantz, Malin
    Giralt, Sergio A.
    Usmani, Saad Z.
    Shahid, Zainab
    Mailankody, Sham
    Lesokhin, Alexander M.
    BLOOD CANCER JOURNAL, 2024, 14 (01):
  • [4] Class comparison of BCMA-directed therapies in relapsed multiple myeloma.
    Matthew, Rees J.
    Mammadzadeh, Aytaj
    Bolarinwa, Abiola
    Elhaj, Mohammed E.
    Bohra, Arwa
    Ailawadhi, Sikander
    Parrondo, Ricardo
    Chhabra, Saurabh
    Lin, Yi
    Binder, Moritz
    Hayman, Suzanne R.
    Dispenzieri, Angela
    Buadi, Francis
    Dingli, David
    Warsame, Rahma M.
    Bansal, Radhika
    Kapoor, Prashant
    Gertz, Morie A.
    Muchtar, Eli
    Kumar, Shaji
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [5] Therapy for Patients with relapsed and/or refractory multiple Myeloma New Data on BCMA-directed therapeutic Approaches
    Rudesheim, Sabine M.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 (04) : 212 - 212
  • [6] Evaluation of Teclistamab in BCMA-Directed Therapy Exposed Versus Naive in Relapsed/Refractory Multiple Myeloma
    Snyder, Jordan
    Graf, Kevin
    Davis, James A.
    Mckenna, Marshall
    Tiger, Yun Kyoung
    Laharwal, Mehak M.
    Mewawalla, Prerna
    Alkharabsheh, Omar
    Hashmi, Hamza
    Shaikh, Hira
    Lochner, Jonathan
    Chang, Darryl
    Atrash, Shebli
    Habib, Alma
    Venkatesh, Priyanka
    Mahmoudjafari, Zahra
    Ahmed, Nausheen
    Mushtaq, Muhammad Umair
    Abdallah, Al-Ola
    Green, Kimberly M.
    Khan, Abdullah Mohammad
    BLOOD, 2024, 144 : 24117 - 24118
  • [7] BCMA-directed CAR T-cell therapy in multiple myeloma
    Cookson, Emma
    LANCET HAEMATOLOGY, 2020, 7 (07): : E505 - E505
  • [8] Early Experience with Salvage RT for Relapsed / Refractory Multiple Myeloma Following BCMA-Directed CART Cell Therapy
    Dreyfuss, A.
    Fregonese, B.
    Mailankody, S.
    Usmani, S.
    Imber, B. S.
    Yahalom, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E618 - E618
  • [9] Risk of Infections with BCMA-Directed Immunotherapy in Multiple Myeloma
    Mohan, Meera
    Nagavally, Sneha
    Dhakal, Binod
    Chhabra, Saurabh
    D'Souza, Anita
    Hari, Parameswaran
    BLOOD, 2021, 138
  • [10] Teclistamab Induces Favorable Responses in Patients with Relapsed and Refractory Multiple Myeloma after Prior BCMA-Directed Therapy
    Grajales-Cruz, Ariel F.
    Castaneda, Omar
    Hansen, Doris K.
    Vazquez-Martinez, Mariola A.
    Blue, Brandon
    Khadka, Sushmita
    Liu, Hien
    Ochoa-Bayona, Jose L.
    Freeman, Ciara Louise L.
    Locke, Frederick L.
    Nishihori, Taiga
    Shain, Kenneth
    Baz, Rachid
    Alsina, Melissa
    BLOOD, 2023, 142
12345